Our Science – Blumenthal Website

Robert Blumenthal, Ph.D.

Selected Publications

1) Zielinski R, Lyakhov I, Jacobs A, Chertov O, Kramer-Marek G, Francella N, Stephen A, Fisher R, Blumenthal R, Capala J.
Affitoxin-A Novel Recombinant, HER2-specific, Anticancer Agent for Targeted Therapy of HER2-positive Tumors.
J. Immunother. 2009. [Journal]

2) Garg H, Joshi A, Blumenthal R.
Altered bystander apoptosis induction and pathogenesis of enfuvirtide-resistant HIV type 1 Env mutants.
AIDS Res. Hum. Retroviruses. 25: 811-7, 2009. [Journal]

3) Wang PC, Blumenthal RP, Zhao Y, Schneider JA, Miller N, Grodzinski P, Gottesman MM, Tinkle S, Wang K, Wang C, Liang XJ.
Building scientific progress without borders: nanobiology and nanomedicine in China and the U.S.
Cancer Res. 69: 5294-5, 2009. [Journal]

4) Kang J, Garg H, Sigano DM, Francella N, Blumenthal R, Marquez VE.
Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency.
Bioorg. Med. Chem. 17(4): 1498-505, 2009. [Journal]

5) Puri A, Blumenthal R.
HIV type 1 Entry Correlates with Plasma Membrane Microdomain Lateral Assemblies of Receptors: Implications in HIV/AIDS Treatment.
Journal of Viral Entry. 3: 103-13, 2009. [Journal]

6) Garg H, Salcedo R, Trinchieri G, Blumenthal R.
Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax.
Cancer Gene Ther. 2009. [Journal]

7) Viard M, Garg H, Blumenthal R, Raviv Y.
Photo-activation of the hydrophobic probe iodonaphthylazide in cells alters membrane protein function leading to cell death.
BMC Cell Biol. 10: 21, 2009. [Journal]

8) Jacobs A, Blumenthal R.
Understanding the Design Principles of Living Systems at the Nanoscale.
Current Nanoscience. 5: 45-50, 2009. Full Text Article. [Journal]

9) Puri A, Kramer-Marek G, Campbell-Massa R, Yavlovich A, Tele SC, Lee SB, Clogston JD, Patri AK, Blumenthal R, Capala J.
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.
Journal of liposome research. 18: 293-307, 2008. [Journal]

10) Thangapazham RL, Puri A, Tele S, Blumenthal R, Maheshwari RK.
Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells.
Int. J. Oncol. 32: 1119-23, 2008. [Journal]

Click Here to View Expanded Bibliography.

This page was last updated on 10/15/2009.